Advertisement

Topics

Cellular therapy just got real: Novartis is the first to get FDA approval for CAR-T treatment

16:01 EDT 30 Aug 2017 | MedCity News

Red seal and imprint "FDA APPROVED" on white surface. FDA - Food and Drug Administration is a federal agency of the United States Department of Health and Human Services.

At $475,000, the therapy isn’t cheap but for its part, Novartis has said patients would only pay the full whack if they respond to the therapy by the end of the first month.

Original Article: Cellular therapy just got real: Novartis is the first to get FDA approval for CAR-T treatment

NEXT ARTICLE

More From BioPortfolio on "Cellular therapy just got real: Novartis is the first to get FDA approval for CAR-T treatment"

Quick Search
Advertisement
 

Relevant Topic

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...